June 22, 2024
Calcium Lactate Market

The global Calcium Lactate Market Growth is driven by increasing necessity in food production

Calcium Lactate is a water-soluble calcium compound that is widely used in food production as a preservative, pH stabilizer, nutrient fortification agent and firming agent. It helps improve product texture and shelf life. Being easily soluble in water and non-toxic, calcium lactate is used to regulate acidity and enhance the calcium content in canned goods, baked products, processed meat and seafood. It is recognized as generally safe (GRAS) by the US Food and Drug Administration (FDA).

The global Calcium Lactate market has witnessed steady growth over the past few decades owing to its versatile functionality and nutritional benefits. Food manufacturers increasingly rely on calcium lactate as an additive to extend shelf life, lock in moisture and improve texture of processed foods. As more people opt for convenience foods and ready-to-eat meals, the demand for effective food preservatives like calcium lactate has grown substantially. Moreover, increasing health consciousness has prompted food companies to fortify their products with important minerals like calcium to meet the daily requirements of consumers.

The global Calcium Lactate Market is estimated to be valued at US$ 1987.2 Mn in 2024 and is expected to exhibit a CAGR of 2.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The calcium lactate market size is expected to witness lucrative opportunities over the forecast period owing to rising demand from the food industry. Food processing companies are focusing on innovating fortified and nutrient-rich food products to appeal to health-conscious consumers. Calcium lactate acts as an ideal calcium fortificant as it is soluble, non-toxic and stable over a wide range of pH. It has found applications in dairy products, sports nutrition products, baked goods, breakfast cereals, meat analogues to enhance calcium content. Furthermore, increasing consumer awareness regarding organic and clean label products is predicted to boost adoption of naturally-derived calcium lactate in the coming years.

Porter’s Analysis

Threat of new entrants: The calcium lactate market requires high capital investment and R&D for product development. Regulatory approval processes also act as barriers for new entrants.

Bargaining power of buyers: The buyers have moderate bargaining power as calcium lactate has applications in various industries like food, beverage, pharmaceutical etc. Buyers can choose substitutes also.

Bargaining power of suppliers: The suppliers have low to moderate bargaining power due to availability of substitutes. Capital investment also acts as a entry barrier.

Threat of new substitutes: Substitutes like calcium carbonate, calcium gluconate etc. provide low to moderate threat. Calcium lactate has unique properties.

Competitive rivalry: The market is moderately competitive with presence of global as well as domestic players. Players adopt strategies like product differentiation, capacity expansion to gain competitive edge.

Key Takeaways

The global calcium lactate market is expected to witness high growth. The global Calcium Lactate Market is estimated to be valued at US$ 1987.2 Mn in 2024 and is expected to exhibit a CAGR of 2.0% over the forecast period 2024 to 2031.

North America dominates the market owing to rising health awareness. The increasing demand from food & beverage industries also supports market growth in the region. Asia Pacific is expected to be the fastest growing market for calcium lactate due to increasing population, changing lifestyle and rising disposable income in the region. Countries like India, China, Japan are expected to witness significant growth.

Key players: Key players operating in the calcium lactate market are Amgen Inc., Johnson & Johnson (Janssen Pharmaceuticals), Pfizer Inc., Roche Holding AG, Novartis AG, Biocon Limited, Teva Pharmaceutical Industries Ltd., LG Chem Ltd., Sandoz International GmbH (a subsidiary of Novartis AG), Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Celltrion Inc., 3SBio Inc., CJ CheilJedang Corporation, BioSidus SA.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraaged AI tools to mine information and compile it